RA
ACOR
Royce & Associates’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,892
| Closed | -$9K | – | 1081 |
|
|
2020
Q4 | $9K | Sell |
12,892
-5,187
| -29% | -$3.62K | ﹤0.01% | 996 |
|
|
2020
Q3 | $9K | Hold |
18,079
| – | – | ﹤0.01% | 989 |
|
|
2020
Q2 | $13K | Hold |
18,079
| – | – | ﹤0.01% | 1127 |
|
|
2020
Q1 | $17K | Sell |
18,079
-7,398
| -29% | -$6.96K | ﹤0.01% | 1105 |
|
|
2019
Q4 | $52K | Hold |
25,477
| – | – | ﹤0.01% | 1036 |
|
|
2019
Q3 | $73K | Buy |
25,477
+1,402
| +6% | +$4.02K | ﹤0.01% | 1016 |
|
|
2019
Q2 | $185K | Buy |
24,075
+21,642
| +890% | +$166K | ﹤0.01% | 994 |
|
|
2019
Q1 | $32K | Buy |
2,433
+790
| +48% | +$10.4K | ﹤0.01% | 1082 |
|
|
2018
Q4 | $26K | Buy |
1,643
+29
| +2% | +$459 | ﹤0.01% | 1068 |
|
|
2018
Q3 | $32K | Buy |
1,614
+1,044
| +183% | +$20.7K | ﹤0.01% | 1087 |
|
|
2018
Q2 | $16K | Buy |
570
+168
| +42% | +$4.72K | ﹤0.01% | 1170 |
|
|
2018
Q1 | $10K | Buy |
+402
| New | +$10K | ﹤0.01% | 1186 |
|